Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017

Transcription

1 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March

2 Contents Summary of PHARMAC decisions effective 1 March... 3 What s changing?... 4 New listings... 4 Potassium chloride tablets (Slow-K) new listing... 4 Escitalopram 10 mg tablet new listing from 14 February... 4 Lidocaine hydrochloride (Lidocaine-Claris) inj 1% and 2% new pack size... 4 Other changes... 5 Dimethicone (healthe Dimethicone 4% Lotion) tender delay... 5 Methyldopa (Prodopa) delisting of 125 mg and 250 mg tablets... 5 Leuprorelin endorsement change... 5 Gefitinib (Iressa) will remain fully funded... 5 Alprazolam price increase reminder... 6 News in brief... 6 Tender News... 7 Looking Forward... 7 Sole Subsidised Supply Products cumulative to March... 8 New Listings Changes to Restrictions, Chemical Names and Presentations Changes to Subsidy and Manufacturer s Price Changes to PSO Delisted Items Items to be Delisted Index

3 New listings (page 23) Summary of PHARMAC decisions EFFECTIVE 1 MARCH Potassium chloride (Slow-K) tab long-acting 600 mg (8 mmol) S29, wastage claimable Lidocaine [lignocaine] hydrochloride (Lidocaine-Claris) inj 1% and 2%, 20 ml vials Up to 5 inj available on a PSO Ondansetron (Apo-Ondansetron) tab 4 mg and 8 mg Changes to restrictions (page 27) Leuprorelin inj 3.75 mg prefilled dual chamber syringe (Lucrin Depot 1 month), 7.5 mg syringe with diluent (Eligard 1 Month), mg prefilled dual chamber syringe (Lucrin Depot 3-month), 22.5 mg syringe with diluent (Eligard 3 Month), 30 mg prefilled dual chamber syringe (Lucrin Depot 6-month), and 45 mg syringe with diluent (Eligard 6 Month) amended restriction Dosulepin [dothiepin] hydrochloride (Dopress) tab 75 mg and cap 25 mg amended chemical name Decreased subsidy (page 36) Mesalazine (Asacol) tab 800 mg Sodium chloride (Multichem and Pfizer) inj 0.9% 5 ml ampoule Sodium chloride (Multichem and Pharmacia) inj 0.9% 10 ml and 20 ml ampoule Water (Multichem) inj 5 ml, 10 ml and 20 ml ampoule 3

4 4 Pharmaceutical Schedule - Update News What s changing? The following Tender product will be listed from 1 March : Ondansetron (Apo-Ondansetron) tab 4 mg and 8 mg New listings Potassium chloride tablets (Slow-K) new listing The Slow K-brand of potassium chloride 600 mg (8 mmol) long-acting tablets will be listed temporarily from 1 March. The Slow-K brand will be listed alongside the Duro-K brand to ensure there are enough potassium chloride 600 mg tablets to meet demand. The Slow-K brand will be supplied under section 29 of the Medicines Act Wastage may be claimed on dispensings of Slow-K. Medsafe is updating the Guidance for Pharmacists Dispensing Prescriptions for Span-K. This can be found on the Medsafe website, at Escitalopram 10 mg tablet new listing from 14 February An additional brand of escitalopram 10 mg tablet, Loxalate, was listed temporarily from 14 February as a result of a supply issue with the Air Flow brand. Loxalate escitalopram 10 mg tablets are supplied by Air Flow. Note that Mylan is supplying Loxalate for the private market at a higher price. We recommend that you manage any existing Loxalate stock supplied by Mylan (for example by quarantining existing packs) while Air Flow is providing this as an alternative. More information for people taking escitalopram can be found at medicines/my-medicine-has-changed/escitalopram Lidocaine hydrochloride (Lidocaine-Claris) inj 1% and 2% new pack size A five injection pack size for lidocaine hydrochloride 1%, 20 ml and 2%, 20 ml injections will be listed from 1 March. The one injection pack sizes for each strength will be discontinued once supplies are exhausted.

5 Pharmaceutical Schedule - Update News 5 Other changes Dimethicone (healthe Dimethicone 4% Lotion) tender delay The listing of the healthe Dimethicone 4% Lotion has been delayed due to manufacturing delays. This product, being listed as a treatment for headlice, will now be listed from 1 May, commencing Sole Supply from 1 October. Methyldopa (Prodopa) delisting of 125 mg and 250 mg tablets The 125 mg and 250 mg strengths of the Prodopa brand of methyldopa will be delisted from 1 September due to supplier discontinuation. In December 2016, we advised that the 500 mg Prodopa would be delisted from June. A 250 mg tablet strength of methyldopa under the brand name Methyldopa Mylan will remain funded. Leuprorelin endorsement change From 1 March, repeat dispensings for leuprorelin will no longer be funded by endorsement. Children or adolescents can continue to receive fully funded leuprorelin if they are unable to tolerate goserelin via prescriber endorsement. Other patients will need to change to goserelin to maintain access to a fully funded treatment. Gefitinib (Iressa) will remain fully funded Gefitinib (Iressa) 250 mg tablets will remain fully funded for eligible patients. We previously notified that the subsidy would reduce from 1 April, but have more recently notified a decision to maintain the subsidy. There will be no changes to the current Special Authority criteria or hospital restrictions for gefitinib.

6 6 Pharmaceutical Schedule - Update News Alprazolam price increase reminder This is a reminder that the price, but not the subsidy, for alprazolam (Xanax) will increase from 1 March. Existing patients will be able to access partly funded alprazolam via endorsement, but will have to pay a manufacturer s surcharge. Alprazolam (Xanax) tablets 250 mcg, 500 mcg and 1 mg are being discontinued and will be delisted from 1 September. We have asked prescribers to consider transitioning their patients to alternative treatments as soon as possible. You can find more information about the change on our website, at News in brief Rizatriptan (Rizamelt) 10 mg orodispersible tablet, 12 tablet pack size will be delisted from 1 September. This product was listed temporarily due to a supply issue which has now been resolved. Cytarabine (Pfizer) 500 mg injection, one injection pack size, will be delisted from 1 September due to supplier discontinuation. Hospira s 5 injection pack size will remain listed. Heparinised saline (Becton Dickinson PosiFlush) 10 iu per ml, 5 ml injection, will be delisted from 1 June. This product was listed temporarily due to a supply issue which has now been resolved. Enteral/oral elemental feed 1kcal/ml (Alitraq) peptide-based oral feed powder. The supplier has discontinued Alitraq and it will be delisted from 1 September. Dosulepin [dothiepin] hydrochloride the chemical name for dothiepin has been amended to dosulepin [dothiepin] to be consistent with Medsafe, NZULM and NZF. You will be able to search our online, PDF and hard copy Schedules using either dotheipin or dosulepin.

7 Tender News Sole Subsidised Supply changes effective 1 April Chemical Name Presentation; Pack size Sole Subsidised Supply brand (and supplier) Capecitabine Tab 150 mg; 60 tab Brinov (Rex Medical) Capecitabine Tab 500 mg; 120 tab Brinov (Rex Medical) Clopidogrel Tab 75 mg; 84 tab Arrow-Clopid (Actavis) Montelukast Tab 4 mg; 28 tab Apo-Montelukast (Apotex) Montelukast Tab 5 mg; 28 tab Apo-Montelukast (Apotex) Montelukast Tab 10 mg; 28 tab Apo-Montelukast (Apotex) Oestradiol Patch 75 mcg per day; 8 patch Estradot (Novartis) Prednisolone acetate Eye drops 1%; 10 ml OP Prednisolone-AFT (AFT) Risedronate sodium Tab 35 mg; 4 tab Risedronate Sandoz (Sandoz) Looking Forward This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Decisions for implementation 1 April Erlotinib (Tarceva) tab 100 mg and 150 mg amended Special Authority criteria Montelukast (Apo-Montelukast) tab 4 mg, 5 mg and 10 mg addition of Brand Switch Fee Venlafaxine (Enlafax XR) cap 37.5 mg, 75 mg and 150 mg new listing Possible decisions for future implementation 1 April Influenza vaccine (Influvac) inj 45 mg in 0.5 ml syringe pharmacist vaccinators subsidy for eligible patients 7

8 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Abacavir sulphate Tab 300 mg Oral liq 20 mg per ml Ziagen Acarbose Tab 50 mg & 100 mg Glucobay Acetazolamide Tab 250 mg Diamox Acetylcysteine Inj 200 mg per ml, 10 ml ampoule DBL Acetycysteine Aciclovir Eye oint 3%, 4.5 g OP Tab dispersible 200 mg, 400 mg & 800 mg ViruPOS Lovir Acitretin Cap 10 mg & 25 mg Novatretin Adult diphtheria and tetanus vaccine Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid in 0.5 ml ADT Booster Allopurinol Tab 100 mg & 300 mg Allopurinol-Apotex Amantadine hydrochloride Cap 100 mg Symmetrel Aminophylline Inj 25 mg per ml, 10 ml ampoule DBL Aminophylline Amiodarone hydrochloride Tab 100 mg & 200 mg Cordarone X Amisulpride Tab 100 mg, 200 mg & 400 mg Oral liq 100 mg per ml Sulprix Solian Amitriptyline Tab 10 mg, 25 mg & 50 mg Arrow-Amitriptyline Amlodipine Tab 2.5 mg, 5 mg & 10 mg Apo-Amlodipine Amorolfine Nail soln 5%, 5 ml OP MycoNail Amoxicillin Amoxicillin with clavulanic acid Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g vials Tab 500 mg with clavulanic acid 125 mg Apo-Amoxi Ibiamox Augmentin Aprepitant Cap 2 x 80 mg and 1 x 125 mg Emend Tri-Pack Aqueous cream Crm, 500 g AFT SLS-free Ascorbic acid Tab 100 mg Cvite Aspirin Tab 100 mg Tab dispersible 300 mg Ethics Aspirin EC Ethics Aspirin Atenolol Tab 50 mg & 100 mg Mylan Atenolol Atorvastatin Tab 10 mg, 20 mg, 40 mg & 80 mg Lorstat Atropine sulphate Eye drops 1%, 15 ml OP Atropt Azathioprine Inj 50 mg vial Imuran Azithromycin Bacillus calmette-guerin vaccine Grans for oral liq 200 mg per 5 ml (40 mg per ml) Tab 250 mg & 500 mg Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent Zithromax Apo-Azithromycin BCG Vaccine 8 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

9 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Baclofen Inj 0.05 mg per ml, 1 ml ampoule Lioresal Intrathecal Bendroflumethiazide [bendrofluazide] Benzathine benzylpenicillin Benzylpenicillin sodium [penicillin G] Tab 2.5 mg & 5 mg Inj 900 mg (1.2 million units) in 2.3 ml syringe Arrow- Bendrofluazide Bicillin LA Inj 600 mg (1 million units) vial Sandoz Betahistine dihydrochloride Tab 16 mg Vergo 16 Betamethasone dipropionate with calcipotriol Betamethasone valerate Betaxolol Bezafibrate Gel 500 mcg with calcipotriol 50 mcg per g, 30 g OP Oint 500 mcg with calcipotriol 50 mcg per g, 30 g OP Crm 0.1%, 50 g OP Oint 0.1%, 50 g OP Eye drops 0.25%, 5 ml OP Eye drops 0.5%, 5 ml OP Tab 200 mg Tab long-acting 400 mg Daivobet Beta Cream Beta Ointment Betoptic S Betoptic Bezalip Bezalip Retard Bicalutamide Tab 50 mg Bicalaccord Bimatoprost Eye drops 0.03%; 3 ml OP Bimatoprost Actavis Bisacodyl Suppos 10 mg Tab 5 mg Lax-Suppositories Lax-Tab Bisoprolol fumarate Tab 2.5 mg, 5 mg & 10 mg Bosvate Bosentan Tab 62.5 mg & 125 mg Mylan-Bosentan Brimonidine tartrate Eye drops 0.2%, 5 ml OP Arrow-Brimonidine Buspirone hydrochloride Tab 5 mg & 10 mg Orion Cabergoline Tab 0.5 mg Dostinex Calamine Crm, aqueous, BP Lotn, BP Pharmacy Health PSM Calcitonin Inj 100 iu per ml, 1 ml ampoule Miacalcic Calcitriol Cap 0.25 mcg & 0.5 mcg Calcitriol-AFT Calcium carbonate Tab 1.25 g (500 mg elemental) Arrow-Calcium Calcium folinate Inj 50 mg Calcium Folinate Ebewe Candesartan cilexetil Tab 4 mg, 8 mg, 16 mg & 32 mg Candestar Carvedilol Tab 6.25 mg, 12.5 mg & 25 mg Dicarz Cefaclor monohydrate Grans for oral liq 125 mg per 5 ml Cap 250 mg Ranbaxy-Cefaclor *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 9

10 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Cefalexin Cap 250 mg Cap 500 mg Grans for oral liq 25 mg per ml Grans for oral liq 50 mg per ml Cephalexin ABM Cephalexin ABM Cefalexin Sandoz Cefazolin Inj 500 mg & 1 g vial AFT Ceftriaxone Cetirizine hydrochloride Inj 1 g vial Inj 500 mg vial Tab 10 mg Oral liq 1 mg per ml DEVA DEVA Zista Histaclear Cetomacrogol Crm BP healthe Cetomacrogol with glycerol Crm 90% with glycerol 10%, 500 ml OP & 1,000 ml OP Chloramphenicol Chlorhexidine gluconate Eye oint 1%, 4 g OP Eye drops 0.5%, 10 ml OP Soln 4% wash Handrub 1% with ethanol 70% Mouthwash 0.2% Pharmacy Health Sorbolene with Glycerin Chlorsig Chlorafast healthe Ciclopirox olamine Nail soln 8%, 7 ml OP Apo-Ciclopirox Cilazapril Tab 2.5 mg & 5 mg Apo-Cilazapril Cilazapril with hydrochlorothiazide Tab 5 mg with hydrochlorothiazide 12.5 mg Apo-Cilazapril/ Hydrochlorothiazide Ciprofloxacin Tab 250 mg, 500 mg & 750 mg Cipflox Citalopram hydrobromide Tab 20 mg PSM Citalopram Clarithromycin Tab 250 mg & 500 mg Apo-Clarithromycin Clindamycin Clobetasol propionate Cap hydrochloride 150 mg Inj phosphate 150 mg per ml, 4 ml ampoule Crm 0.05%, 30 g OP Oint 0.05%, 30 g OP Clindamycin ABM Dalacin C Dermol Clomipramine hydrochloride Tab 10 mg & 25 mg Apo-Clomipramine Clonidine Patch 2.5 mg, 100 mcg per day Patch 5 mg, 200 mcg per day Patch 7.5 mg, 300 mcg per day Catapres TTS 1 Catapres TTS 2 Catapres TTS 3 Clonidine hydrochloride Tab 25 mcg Clonidine BNM Clotrimazole Vaginal crm 1% with applicators, 35 g OP Vaginal crm 2% with applicators, 20 g OP Crm 1%, 20 g OP Clomazol Coal tar Soln BP Midwest Compound electrolytes Powder for oral soln Enerlyte Crotamiton Crm 10%, 20 g OP Itch-Soothe 10 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

11 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Cyclizine hydrochloride Tab 50 mg Nauzene Cyclopentolate hydrochloride Eye drops 1%, 15 ml OP Cyclogyl Cyproterone acetate Tab 50 mg & 100 mg Procur Cyproterone acetate with ethinyloestradiol Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets Ginet Dapsone Tab 25 mg & 100 mg Dapsone Desferrioxamine mesilate Inj 500 mg vial Desferal Desmopressin acetate Dexamethasone Dexamethasone with neomycin sulphate and polymyxin B sulphate Tab 100 mcg & 200 mcg Nasal spray 10 mcg per dose, 6 ml OP Tab 0.5 mg & 4 mg Eye drops 0.1%, 5 ml OP Eye oint 0.1%, 3.5 g OP Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml, 5 ml OP Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per g, 3.5 g OP Minirin Desmopressin-PH&T Dexmethsone Maxidex Maxitrol Dexamfetamine sulfate Tab 5 mg PSM Diclofenac sodium Digoxin Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Inj 25 mg per ml, 3 ml ampoule Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Eye drops 0.1%, 5 ml OP Tab 62.5 mcg Tab 250 mcg Diclofenac Sandoz Apo-Diclo SR Voltaren Voltaren Ophtha Lanoxin PG Lanoxin Dihydrocodeine tartrate Tab long-acting 60 mg DHC Continus Dimethicone Diphtheria, tetanus and pertussis vaccine Diphtheria, tetanus, pertussis and polio vaccine Crm 5%, pump bottle, 500 ml OP Crm 10% pump bottle, 500 ml OP Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagluttinin and 2.5 mcg pertactin in 0.5 ml syringe Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagluttinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml healthe Dimethicone 5% healthe Dimethicone 10% Boostrix Infanrix IPV *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 11

12 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagluttinin, 8 mcg pertactin, 80 D-AgU polio virus, 10 mcg hepatitis B surface antigen in 0.5 ml syringe and inj 10 mcg haemophilus influenza Infanrix-hexa Dipyridamole Tab long-acting 150 mg Pytazen SR Docusate sodium Tab 50 mg & 120 mg Coloxyl Domperidone Tab 10 mg Prokinex Donepezil hydrochloride Tab 5 mg & 10 mg Donepezil-Rex Dorzolamide with timolol Eye drops 2% with timolol 0.5%, 5 ml OP Arrow-Dortim Doxazosin Tab 2 mg & 4 mg Apo-Doxazosin Doxycycline Tab 100 mg Doxine Efavirenz Tab 50 mg, 200 mg & 600 mg Stocrin Emulsifying ointment Oint BP AFT Enalapril maleate Tab 5 mg, 10 mg & 20 mg Ethics Enalapril Entacapone Tab 200 mg Entapone Epoetin alfa [erythropoietin alfa] Inj 1,000 iu in 0.5 ml, syringe Inj 2,000 iu in 0.5 ml, syringe Inj 3,000 iu in 0.3 ml, syringe Inj 4,000 iu in 0.4 ml, syringe Inj 5,000 iu in 0.5 ml, syringe Inj 6,000 iu in 0.6 ml, syringe Inj 8,000 iu in 0.8 ml, syringe Inj 10,000 iu in 1 ml, syringe Inj 40,000 iu in 1 ml, syringe Eprex 28/2/18 Ergometrine maleate Inj 500 mcg per ml, 1 ml ampoule DBL Ergometrine Ethinyloestradiol Tab 10 mcg NZ Medical and Scientific Etidronate disodium Tab 200 mg Arrow-Etidronate Etoposide Inj 20 mg per ml, 5 ml vial Rex Medical Exemestane Tab 25 mg Pfizer Exemestane Ezetimibe Tab 10 mg Ezemibe Ezetimibe with simvastatin Felodipine Tab 10 mg with simvastatin 10 mg Tab 10 mg with simvastatin 20 mg Tab 10 mg with simvastatin 40 mg Tab 10 mg with simvastatin 80 mg Tab long-acting 2.5 mg, 5 mg & 10 mg Zimybe Plendil ER 12 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

13 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Fentanyl Inj 50 mcg per ml, 2 ml & 10 ml ampoule Boucher and Muir Ferrous fumarate Tab 200 mg (65 mg elemental) Ferro-tab Ferrous sulphate Oral liq 30 mg (6 mg elemental) per ml Ferodan Finasteride Tab 5 mg Finpro Flucloxacillin Grans for oral liq 25 mcg per ml Grans for oral liq 50 mcg per ml Cap 250 mg & 500 mg Inj 250 mg vial, 500 mg vial & 1 g vial AFT Staphlex Flucloxin Fluconazole Cap 50 mg, 150 mg & 200 mg Ozole Fludarabine phosphate Tab 10 mg Fludara Oral Fluorometholone Eye drops 0.1%, 5 ml OP FML Fluorouracil sodium Crm 5%, 20 g OP Efudix Fluoxetine hydrochloride Fluticasone propionate Cap 20 mg Tab dispersible 20 mg, scored Metered aqueous nasal spray, 50 mcg per dose Arrow-Fluoxetine Flixonase Hayfever & Allergy Folic acid Tab 0.8 mg & 5 mg Apo-Folic Acid Furosemide [frusemide] Inj 10 mg per ml, 2 ml ampoule Tab 40 mg Tab 500 mg Frusemide-Claris Diurin 40 Urex Forte Galsulfase Inj 1 mg per ml, 5 ml vial Naglazyme Gemfibrozil Tab 600 mg Lipazil Gentamicin sulphate Inj 40 mg per ml, 2 ml ampoule Pfizer Gliclazide Tab 80 mg Glizide Glipizide Tab 5 mg Minidiab Glucose [dextrose] Glycerol Glyceryl trinitrate Inj 50%, 10 ml ampoule Inj 50%, 90 ml bottle Suppos 3.6 g Liquid Patch 25 mg, 5 mg per day Patch 50 mg, 10 mg per day Biomed PSM healthe Glycerol BP Nitroderm TTS 5 Nitroderm TTS 10 Goserelin Implant 3.6 mg & 10.8 mg Zoladex Granisetron Tab 1 mg Granirex Haemophilus influenzae type B vaccine Haloperidol Hepatitis A vaccine Inj 10 mcg vial with diluent syringe Act-HIB Tab 500 mcg, 1.5 mg & 5 mg Oral liq 2 mg per ml Inj 5 mg per ml, 1 ml ampoule Inj 1440 ELISA units in 1 ml syringe Inj 720 ELISA units in 1 ml syringe Serenace Havrix Havrix Junior *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 13

14 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Hepatitis B recombinant vaccine Human papillomavirus (6,11,16 and 18) vaccine [HPV] Hydrocortisone Hydrocortisone acetate Hydrocortisone and paraffin liquid and lanolin Hydrocortisone with miconazole Inj 5 mcg per 0.5 ml vial Inj 10 mg per 1 ml vial Inj 40 mg per 1 ml vial HBvaxPRO Inj 120 mcg in 0.5 ml syringe Gardasil Crm 1%, 500 g Inj 100 mg vial Tab 5 mg & 20 mg Powder Rectal foam 10%, CFC-free (14 applications), 21.1 g OP Lotn 1% with paraffin liquid 15.9% and lanolin 0.6% Crm 1% with miconazole nitrate 2%, 15 g OP Pharmacy Health Solu-Cortef Douglas ABM Colifoam DP Lotn HC Micreme H Hydrogen peroxide Soln 3% (10 vol) Pharmacy Health Hydroxocobalamin Inj 1 mg per ml, 1 ml ampoule Neo-B12 Hydroxychloroquine Tab 200 mg Plaquenil Ibuprofen Tab long-acting 800 mg Tab 200 mg Brufen SR Ibugesic Imatinib mesilate Cap 100 mg Imatinib-AFT Imiquimod Crm 5%, 250 mg sachet Apo-Imiquimod Cream 5% Indapamide Tab 2.5 mg Dapa-Tabs Influenza vaccine Inj 45 mcg in 0.5 ml syringe Influvac 31/12/19 Ipratropium bromide Nebuliser soln, 250 mcg per ml, 1 ml ampoule Nebuliser soln, 250 mcg per ml, 2 ml ampoule Aqueous nasal spray, 0.03% Univent Univent Iron polymaltose Inj 50 mg per ml, 2 ml ampoule Ferrum H Isoniazid Isosorbide mononitrate Tab 100 mg Tab 100 mg with rifampicin 150 mg Tab 150 mg with rifampicin 300 mg Tab long-acting 40 mg Tab 20 mg PSM Rifinah Ismo 40 Retard Ismo-20 Itraconazole Cap 100 mg Itrazole Ketoconazole Shampoo 2%, 100 ml OP Sebizole Lactulose Oral liq 10 g per 15 ml Laevolac Lamivudine Tab 100 mg Oral liq 5 mg per ml Zeffix Lansoprazole Cap 15 mg & 30 mg Lanzol Relief 14 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

15 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Latanoprost Eye drops 0.005%, 2.5 ml OP Hysite Letrozole Tab 2.5 mg Letrole Levomepromazine hydrochloride Levonorgestrel Lidocaine [lignocaine] hydrochloride Inj 25 mg per ml, 1 ml ampoule Wockhardt Intra-uterine system 20 mcg per day Subdermal implant (2 x 75 mg rods) Mirena Jadelle 31/12/17 Oral (viscous) soln 2% Xylocaine Viscous Lisinopril Tab 5 mg, 10 mg & 20 mg Ethics Lisinopril Lithium carbonate Tab 250 mg & 400 mg Cap 250 mg Lithicarb FC Douglas Lodoxamide Eye drops 0.1%, 10 ml OP Lomide Loperamide hydrochloride Tab 2 mg Cap 2 mg Nodia Diamide Relief Loratadine Tab 10 mg Lorafix Lorazepam Tab 1 mg & 2.5 mg Ativan Losartan potassium Losartan potassium with hydrochlorothiazide Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride Tab 12.5 mg, 25 mg, 50 mg & 100 mg Tab 50 mg with hydrochlorothiazide 12.5 mg Powder for oral soln g with potassium chloride 46.6 mg, sodium bicarbonate mg and sodium chloride mg Losartan Actavis Arrow-Losartan & Hydrochlorothiazide Lax-Sachets Magnesium sulphate Inj 2 mmol per ml, 5 ml ampoule DBL Mask for spacer device Small e-chamber Mask Measles, mumps and rubella vaccine Inj 1000 TCID50 measles, TCID50 mumps and 1000 TCID50 rubella vial with diluent 0.5 ml vial M-M-R II Mebeverine hydrochloride Tab 135 mg Colofac Medroxyprogesterone Tab 2.5 mg, 5 mg & 10 mg Tab 100 mg Inj 150 mg per ml, 1 ml syringe Provera Provera HD Depo-Provera Megestrol acetate Tab 160 mg Apo-Megestrol Meningococcal C conjugate vaccine Meningococcal (groups a,c,y and w-135) congugate vaccine Mesalazine Inj 10 mcg in 0.5 ml syringe Neisvac-C Inj 4 mcg of each meningococcal polysaccharide conjugated to a total of approximately 48 mcg of diphtheria toxoid carrier per 0.5 ml vial Enema 1 g per 100 ml Suppos 1 g Menactra Pentasa Pentasa *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 15

16 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Metformin hydrochloride Tab immediate-release 500 mg Metchek Methadone hydrochloride Methotrexate Tab 5 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 25 mg per ml, 2 ml & 20 ml vials Tab 2.5 mg & 10 mg Inj 100 mg per ml, 50 ml Methatabs Biodone Biodone Forte Biodone Extra Forte DBL Methotrexate Onco-Vial Trexate Methotrexate Ebewe Methylprednisolone Tab 4 mg & 100 mg Medrol Methylprednisolone (as sodium succinate) Inj 40 mg vial Inj 125 mg vial Inj 500 mg vial Inj 1 g vial Solu-Medrol Methylprednisolone acetate Inj 40 mg per ml, 1 ml vial Depo-Medrol Methylprednisolone acetate with lidocaine [lignocaine] Metoclopramide hydrochloride Inj 40 mg per ml with lidocaine [lignocaine] 1 ml vial Tab 10 mg Inj 5 mg per ml, 2 ml ampoule Depo-Medrol with Lidocaine Metamide Pfizer Metoprolol tartrate Tab 50 mg & 100 mg Apo-Metoprolol Miconazole Oral gel 20 mg per g Decozol Miconazole nitrate Crm 2%, 15 g OP Vaginal crm 2% with applicator, 40 g OP Multichem Micreme Mirtazapine Tab 30 mg & 45 mg Apo-Mirtazapine Misoprostol Tab 200 mcg Cytotec Mitomycin C Inj 5 mg vial Arrow Moclobemide Tab 150 mg & 300 mg Apo-Moclobemide Mometasone furoate Morphine hydrochloride Morphine sulphate Crm 0.1%, 15 g OP & 50 g OP Oint 0.1%, 15 g OP & 50 g OP Lotn 0.1%, 30 ml OP Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab long-acting 10 mg, 30 mg, 60 mg & 100 mg Tab immediate-release 10 mg & 20 mg Inj 5 mg per ml, 1 ml ampoule Inj 10 mg per ml, 1 ml ampoule Inj 15 mg per ml, 1 ml ampoule Inj 30 mg per ml, 1 ml ampoule Elocon Alcohol Free Elocon RA-Morph Arrow-Morphine LA Sevredol DBL Morphine Sulphate 16 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

17 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Morphine tartrate Inj 80 mg per ml, 1.5 ml ampoule DBL Morphine Tartrate Nadolol Tab 40 mg & 80 mg Apo-Nadolol Naphazoline hydrochloride Eye drops 0.1%, 15 ml OP Naphcon Forte Naproxen Tab 250 mg Tab 500 mg Tab long-acting 750 mg Tab long-acting 1 g Noflam 250 Noflam 500 Naprosyn SR 750 Naprosyn SR 1000 Neostigmine metilsulfate Inj 2.5 mg per ml, 1 ml ampoule AstraZeneca Nevirapine Tab 200 mg Nevirapine Alphapharm Nicotine Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit & Mint) Habitrol Nicotinic acid Tab 50 mg & 500 mg Apo-Nicotinic Acid Nifedipine Tab long-acting 30 mg & 60 mg Adefin XL Nitrazepam Tab 5 mg Nitrodos Norethisterone Tab 350 mcg Tab 5 mg Noriday 28 Primolut N Norfloxacin Tab 400 mg Arrow-Norfloxacin Nortriptyline hydrochloride Tab 10 mg & 25 mg Norpress Nystatin Oral liq 100,000 u per ml, 24 ml OP m-nystatin Octreotide Oestradiol Inj 50 mcg per ml, 1 ml vial Inj 100 mcg per ml, 1 ml vial Inj 500 mcg per ml, 1 ml vial Patch 50 mcg per day Patch 100 mcg per day Patch 25 mcg per day DBL Estradot 50 mcg Estradot Estradot Oestradiol valerate Tab 1 mg & 2 mg Progynova Oil in water emulsion Crm; 500 g O/W Fatty Emulsion Cream Olanzapine Omeprazole Ondansetron Tab 2.5 mg, 5 mg & 10 mg Tab orodispersible 5 mg & 10 mg Inj 40 mg ampoule with diluent Cap 10 mg, 20 mg & 40 mg Tab disp 4 mg Tab disp 8 mg Zypine Zypine ODT Dr Reddy s Omeprazole Omezol Relief Dr Reddy s Ondansetron Ondansetron ODT- DRLA Ornidazole Tab 500 mg Arrow-Ornidazole Oxazepam Tab 10 mg & 15 mg Ox-Pam *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 17

18 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Oxybutynin Oxycodone hydrochloride Oxytocin Oxytocin with ergometrine maleate Pamidronate disodium Pancreatic enzyme Oral liq 5 mg per 5 ml Tab 5 mg Tab controlled-release 5 mg, 10 mg, 20 mg, 40 mg & 80 mg Inj 10 mg per ml, 1 ml & 2 ml ampoules Inj 50 mg per ml, 1 ml ampoule Cap immediate-release 5 mg, 10 mg & 20 mg Inj 5 iu per ml, 1 ml ampoule Inj 10 iu per ml, 1 ml ampoule Inj 5 iu with ergometrine maleate 500 mcg per ml Inj 3 mg per ml, 10 ml vial Inj 6 mg per ml, 10 ml vial Inj 9 mg per ml, 10 ml vial Cap pancreatin 150 mg (amylase 8,000 Ph Eur U, lipase 10,000 Ph Eur U, total protease 600 Ph Eur U) Cap pancreatin 300 mg (amylase 18,000 Ph Eur U, lipase 25,000 Ph Eur U, total protease 1,000 Ph Eur U) Apo-Oxybutynin BNM OxyNorm Oxytocin BNM Syntometrine Pamisol Creon Creon Pantoprazole Tab EC 20 mg & 40 mg Panzop Relief Paracetamol Paracetamol with codeine Suppos 125 mg & 250 mg Suppos 500 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Paraffin liquid with wool fat Eye oint 3% with wool fat 3%, 3.5 g OP Peak flow meter Pegylated interferon alfa-2a Low range Normal range Inj 180 mcg prefilled syringe Inj 135 mcg prefilled syringe 4 with ribavirin tab 200 mg 168 Inj 180 mcg prefilled syringe 4 with ribavirin tab 200 mg 112 Inj 180 mcg prefilled syringe 4 with ribavirin tab 200 mg 168 Gacet Paracare Pharmacare Paracare Paracare Double Strength Paracetamol + Codeine (Relieve) Poly-Visc Mini-Wright AFS Low Range Mini-Wright Standard Pegasys Pegasys RBV Combination Pack Perhexiline maleate Tab 100 mg Pexsig Perindopril Tab 2 mg & 4 mg Apo-Perindopril Permethrin Crm 5%, 30 g OP Lotn 5%, 30 ml OP Lyderm A-Scabies 18 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

19 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Pethidine hydrochloride Tab 50 mg & 100 mg Inj 50 mg per ml, 1 ml & 2 ml PSM DBL Pethidine Hydrochloride Phenobartitone Tab 15 mg & 30 mg PSM Phenoxymethylpenicillin (penicillin V) Phenytoin sodium Pilocarpine hydrochloride Pine tar with trolamine laurilsulfate and fluorescein Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 250 mg & 500 mg Inj 50 mg per ml, 2 ml ampoule Inj 50 mg per ml, 5 ml ampoule Eye drops 1%, 15 ml OP Eye drops 2%, 15 ml OP Eye drops 4%, 15 ml OP Soln 2.3% with trolamine laurilsulfate and fluorescein sodium AFT Cilicaine VK Hospira Isopto Carpine Pinetarsol Pioglitazone Tab 15 mg, 30 mg & 45 mg Vexazone Pizotifen Tab 500 mcg Sandomigran Pneumococcal (PCV13) vaccine Pneumococcal (PPV23) polysaccharide vaccine Inj 30.8 mcg in 0.5 ml syringe Prevenar 13 Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) Pneumovax 23 Poliomyelitis vaccine Inj 80D antigen units in 0.5 ml syringe IPOL Poloxamer Oral drops 10%, 30 ml OP Coloxyl Polyvinyl alcohol Potassium iodate Eye drops 1.4%, 15 ml OP Eye drops 3%, 15 ml OP Tab 253 mcg (150 mcg elemental iodine) Vistil Vistil Forte NeuroTabs Pramipexole hydrochloride Tab 0.25 mg & 1 mg Ramipex Pravastatin Tab 20 mg & 40 mg Cholvastin Pregnancy tests HCG urine Cassette EasyCheck Procaine penicillin Inj 1.5 g in 3.4 ml syringe Cilicaine Prochlorperazine Tab 5 mg Antinaus Progesterone Cap 100 mg Urogestan Promethazine hydrochloride Inj 25 mg per ml, 2 ml ampoule Oral liq 1 mg per ml Tab 10 mg & 25 mg Hospira Allersoothe Pyridostigmine bromide Tab 60 mg Mestinon Pyridoxine hydrochloride Quetiapine Tab 25 mg Tab 50 mg Tab 25 mg, 100 mg, 200 mg & 300 mg Vitamin B6 25 Apo-Pyridoxine Quetapel *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 19

20 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Quinapril Quinapril with hydrochlorothiazide Ranitidine Tab 5 mg Tab 10 mg Tab 20 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Tab 150 mg & 300 mg Oral liq 150 mg per 10 ml Arrow-Quinapril 5 Arrow-Quinapril 10 Arrow-Quinapril 20 Accuretic 10 Accuretic 20 Ranitidine Relief Peptisoothe Rifabutin Cap 150 mg Mycobutin Rifampicin Cap 150 mg & 300 mg Oral liq 100 mg per 5 ml Rifadin Rifaximin Tab 550 mg Xifaxan Risperidone Tab 0.5 mg, 1 mg, 2 mg, 3 mg & 4 mg Oral liq 1 mg per ml Actavis Risperon Rizatriptan Tab orodispersible 10 mg Rizamelt Ropinirole hydrochloride Tab 0.25 mg, 1 mg, 2 mg & 5 mg Apo-Ropinirole Rotavirus live reassortant oral vaccine Salbutamol Salbutamol with ipratropium bromide Oral susp G1, G2, G3, G4, P1(8) 11.5 million CCID50 Nebuliser soln, 1 mg per ml, 2.5 ml ampoule Nebuliser soln, 2 mg per ml, 2.5 ml ampoule Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml ampoule RotaTeq Asthalin Duolin Sertraline Tab 50 mg & 100 mg Arrow-Sertraline Sildenafil Tab 25 mg, 50 mg & 100 mg Vedafil Siltuximab Inj 100 mg & 400 mg vials Sylvant Simvastatin Sodium chloride Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Inj 23.4% (4 mmol/ml), 20 ml ampoule Inj 0.9%, bag; 500 ml & 1,000 ml Arrow-Simva 10mg Arrow-Simva 20mg Arrow-Simva 40mg Arrow-Simva 80mg Biomed Baxter Sodium citro-tartrate Grans effervescent 4 g sachets Ural Sodium cromoglycate Eye drops 2%, 5 ml OP Rexacrom Sodium polystyrene sulphonate Powder Resonium A Somatropin Inj cartridges 5 mg, 10 mg & 15 mg Omnitrope 31/12/17 Sotalol Tab 80 mg & 160 mg Mylan 20 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

21 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Spacer device 220 ml (single patient) e-chamber Turbo Spironolactone Tab 25 mg & 100 mg Spiractin Sulphasalazine Tab 500 mg Tab EC 500 mg Salazopyrin Salazopyrin EN Tacrolimus Cap 0.5 mg, 1 mg & 5 mg Tacrolimus Sandoz 31/10/18 Temazepam Tab 10 mg Normison Tenoxicam Tab 20 mg Tilcotil Terazosin Tab 1 mg Actavis Terbinafine Tab 250 mg Dr Reddy s Terbinafine Testosterone cypionate Inj 100 mg per ml, 10 ml vial Depo-Testosterone Testosterone undecanoate Cap 40 mg Andriol Testocaps Tetrabenazine Tab 25 mg Motelis Thymol glycerin Compound, BPC PSM Timolol Tobramycin Eye drops 0.25%, gel forming, 2.5 ml OP Eye drops 0.5%, gel forming, 2.5 ml OP Eye drops 0.25%, 5 ml OP Eye drops 0.5%, 5 ml OP Eye drops 0.3%, 5 ml OP Eye oint 0.3%, 3.5 g OP Timoptol XE Arrow-Timolol Tobrex Tolcapone Tab 100 mg Tasmar Tramadol hydrchloride Cap 50 mg Tab sustained-release 100 mg Tab sustained-release 150 mg Tab sustained-release 200 mg Arrow-Tramadol Tramal SR 100 Tramal SR 150 Tramal SR 200 Tranexamic acid Tab 500 mg Cyklolapron Triamcinolone acetonide Paste 0.1% Oint 0.02%, 100 g OP Crm 0.02%, 100 g OP Inj 10 mg per ml, 1 ml ampoule Inj 40 mg per ml, 1 ml ampoule Kenalog in Orabase Aristocort Aristocort Kenacort-A 10 Kenacort-A 40 Trimethoprim Tab 300 mg TMP Tropicamide Eye drops 0.5%, 15 ml OP Eye drops 1%, 15 ml OP Mydriacyl Urea Crm 10%, 100 g OP healthe Urea Cream Ursodeoxycholic acid Cap 250 mg Ursosan Valaciclovir Tab 500 mg & 1,000 mg Vaclovir Valganciclovir Tab 450 mg Valcyte Vancomycin Inj 500 mg Mylan *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table. 21

22 Sole Subsidised Supply Products cumulative to March Generic Name Presentation Brand Name Expiry Date* Varicella vaccine [chicken pox vaccine] Inj 2,000 PFU vial with diluent Varilix Verapamil hydrochloride Tab 80 mg Isoptin Vitamin B complex Tab, strong, BPC Bplex Vitamins Tab (BPC cap strength) Mvite Voriconazole Tab 50 mg & 200 mg Vttack Zidovudine [AZT] Zidovudine [AZT] with lamivudine Cap 100 mg Oral liq 10 mg per ml, 200 ml OP Retrovir Tab 300 mg with lamivudine 150 mg Alphapharm Zinc sulphate Cap mg (50 mg elemental) Zincaps Ziprasidone Cap 20 mg, 40 mg, 60 mg & 80 mg Zusdone Zopiclone Tab 7.5 mg Zopiclone Actavis March changes are in bold type 22 *Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

23 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised New Listings Effective 1 March 55 POTASSIUM CHLORIDE Tab long-acting 600 mg (8 mmol) Slow-K S29 Wastage claimable see rule LIDOCAINE [LIGNOCAINE] HYDROCHLORIDE Inj 1%, 20 ml vial Up to 5 inj available on a PSO Lidocaine-Claris Inj 2%, 20 ml vial Up to 5 inj available on a PSO Lidocaine-Claris 144 ONDANSETRON Tab 4 mg Apo-Ondansetron Tab 8 mg Apo-Ondansetron Effective 14 February 137 ESCITALOPRAM Tab 10 mg Loxalate Effective 1 February 25 METFORMIN HYDROCHLORIDE Tab immediate-release 850 mg Apotex 56 TERAZOSIN Tab 2 mg Apo-Terazosin 90 CARBIMAZOLE Tab 5 mg AFT Carbimazole S29 Wastage claimable see rule PAROXETINE Tab 20 mg Apo-Paroxetine 143 SUMATRIPTAN Inj 12 mg per ml, 0.5 ml prefilled pen Maximum of 10 inj per prescription OP Clustran 219 PHARMACY SERVICES May only be claimed once per patient. Brand switch fee fee BSF Lorstat BSF Sulprix a) The Pharmacode for BSF Lorstat is b) The Pharmacode for BSF Sulprix is Effective 16 January 54 PEGFILGRASTIM Special Authority see SA1384 Retail pharmacy Inj 6 mg per 0.6 ml syringe...1, Neulastim Note This is the listing of a new Pharmacode, Three months supply may be dispensed at one time if endorsed certified exemption by the prescriber or pharmacist Three months or six months, as applicable, dispensed all-at-once 23

24 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised New Listings effective 1 January 137 ESCITALOPRAM Tab 10 mg Accord Escitalopram 54 SODIUM CHLORIDE Not funded for use as a nasal drop. Only funded for nebuliser use when in conjunction with an antibiotic intended for nebuliser use. Inj 0.9%, 5 ml ampoule Up to 5 inj available on a PSO InterPharma Inj 0.9%, 20 ml ampoule InterPharma 55 WATER 1) On a prescription or Practitioner s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or 2) On a bulk supply order; or 3) When used in the extemporaneous compounding of eye drops. Inj 5 ml ampoule Up to 5 inj available on a PSO InterPharma Inj 10 ml ampoule Up to 5 inj available on a PSO Pfizer Inj 20 ml ampoule Up to 5 inj available on a PSO InterPharma 59 METOPROLOL SUCCINATE Tab long-acting 95 mg Myloc CR 88 OESTRADIOL See prescribing guideline Patch 75 mcg per day Estradot a) No more than 2 patch per week b) Only on a prescription 107 PYRAZINAMIDE Retail pharmacy-specialist a) No patient co-payment payable b) Prescriptions must be written by, or on the recommendation of, an infectious disease physician, clinical microbiologist or respiratory physician Tab 500 mg For pyrazinamide oral liquid formulation refer AFT-Pyrazinamide Wastage claimable see rule S29 S TRIFLUOPERAZINE HYDROCHLORIDE Subsidy by endorsement a) Safety medicine; prescriber may determine dispensing frequency b) Subsidised for patients who were taking trifluoperazine hydrochloride prior to 1 January and the prescription is endorsed accordingly. Pharmacists may annotate the prescription as endorsed where there exists a record of prior dispensing of trifluoperazine hydrochloride. Tab 1 mg Apo-Trifluoperazine S29 Wastage claimable see rule Tab 5 mg Apo-Trifluoperazine S29 Wastage claimable see rule FLUPHENAZINE DECANOATE Subsidy by endorsement a) Safety medicine; prescriber may determine dispensing frequency b) Subsidised for patients who were taking fluphenazine decanoate prior to 1 December 2016 and the prescription or PSO is endorsed accordingly. Pharmacists may annotate the prescription as endorsed where there exists a record of prior dispensing of fluphenazine decanoate. Inj 25 mg per ml, 1 ml Up to 5 inj available on a PSO Modecate S29 S29 Wastage claimable see rule Patients pay a manufacturer s surcharge when the Manufacturer s Price is greater than the Subsidy 24 S29 Unapproved medicine supplied under Section 29 safety cap reimbursed Sole Subsidised Supply

25 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised New Listings effective 1 January (continued) 184 ETANERCEPT Special Authority see SA1620 Retail pharmacy Inj 50 mg autoinjector...1, Enbrel Note This is the listing of an alternate Pharmacode, OBINUTUZUMAB PCT only Specialist Special Authority see SA1627 Inj 25 mg per ml, 40 ml vial...5, Gazyva Inj 1 mg for ECP mg Baxter SA1627 Special Authority for Subsidy Initial application (chronic lymphocytic leukaemia) only from a haematologist. Approvals valid for 12 months for applications meeting the following criteria: All of the following: 1 The patient has progressive Binet stage A, B or C CD20+ chronic lymphocytic leukaemia requiring treatment; and 2 The patient is obinutuzumab treatment naive; and 3 The patient is not eligible for full dose FCR due to comorbidities with a score > 6 on the Cumulative Illness Rating Scale (CIRS) or reduced renal function (creatinine clearance <70mL/min); and 4 Patient has adequate neutrophil and platelet counts ( 1.5 x 10 9 /L and platelets 75 x 10 9 /L) unless the cytopenias are a consequence of marrow infiltration by CLL; and 5 Patient has good performance status; and 6 Obinutuzumab to be administered at a maximum cumulative dose of 8,000 mg and in combination with chlorambucil for a maximum of 6 cycles. Notes: Chronic lymphocytic leukaemia includes small lymphocytic lymphoma. Comorbidity refers only to illness/ impairment other than CLL induced illness/impairment in the patient. Good performance status means ECOG score of 0-1, however, in patients temporarily debilitated by their CLL disease symptoms a higher ECOG (2 or 3) is acceptable where treatment with obinutuzumab is expected to improve symptoms and improve ECOG score to < PERTUZUMAB PCT only Specialist Special Authority see SA1606 Inj 30 mg per ml, 14 ml vial...3, Perjeta Inj 1 mg for ECP mg Baxter SA1606 Special Authority for Subsidy Initial application (metastatic breast cancer) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following: 1 The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology); and 2 Either: 2.1 Patient is chemotherapy treatment naïve; or 2.2 Patient has not received prior treatment for their metastatic disease and has had a treatment free interval of at least 12 months between prior (neo)adjuvant chemotherapy treatment and diagnosis of metastatic breast cancer; and 3 The patient has good performance status (ECOG grade 0-1); and 4 Pertuzumab to be administered in combination with trastuzumab; and 5 Pertuzumab maximum first dose of 840 mg, followed by maximum of 420 mg every 3 weeks; and 6 Pertuzumab to be discontinued at disease progression. Renewal (metastatic breast cancer) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Both: 1 The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology); and 2 The cancer has not progressed at any time point during the previous 12 months whilst on pertuzumab and trastuzumab. Three months supply may be dispensed at one time if endorsed certified exemption by the prescriber or pharmacist Three months or six months, as applicable, dispensed all-at-once 25

26 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised New Listings effective 1 January (continued) 212 PIRFENIDONE Retail pharmacy-specialist Special Authority see SA1628 Cap 267 mg...3, OP Esbriet SA1628 Special Authority for Subsidy Initial application (idiopathic pulmonary fibrosis) only from a respiratory specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following: 1 Patient has been diagnosed with idiopathic pulmonary fibrosis as confirmed by histology, CT or biopsy; and 2 Forced vital capacity is between 50% and 80% predicted; and 3 Pirfenidone is to be discontinued at disease progression (See Notes). Renewal (idiopathic pulmonary fibrosis) only from a respiratory specialist. Approvals valid for 12 months for applications meeting the following criteria: Both: 1 Treatment remains clinically appropriate and patient is benefitting from and tolerating treatment; and 2 Pirfenidone is to be discontinued at disease progression (See Notes). Notes: disease progression is defined as a decline in percent predicted FVC of 10% or more within any 12 month period. 260 HUMAN PAPILLOMAVIRUS (6, 11, 16, 18, 31, 33, 45, 52 AND 58) VACCINE [HPV] [Xpharm] Any of the following: 1 Maximum of two doses for children aged 14 years and under; or 2 Maximum of three doses for patients meeting any of the following criteria: 2.1 People aged 15 to 26 years inclusive; or 2.2 Either: People aged 9 to 26 years inclusive; and Confirmed HIV; or Transplant (including stem cell) patients: or 3 Maximum of four doses for people aged 9 to 26 years inclusive post chemotherapy. Inj 270 mcg in 0.5 ml syringe Gardasil 9 Effective 22 November POTASSIUM CHLORIDE Tab long-acting 600 mg (8 mmol) Duro-K S29 Wastage claimable see rule SODIUM BICARBONATE Cap 840 mg Sodibic Note This is the listing of an alternate Pharmacode, Patients pay a manufacturer s surcharge when the Manufacturer s Price is greater than the Subsidy 26 S29 Unapproved medicine supplied under Section 29 safety cap reimbursed Sole Subsidised Supply

27 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised Changes to Restrictions, Chemical Names and Presentations Effective 1 March 95 LEUPRORELIN Additional subsidy by endorsement where the patient is a child or adolescent and is unable to tolerate administration of goserelin and the prescription is endorsed accordingly; or the patient has outstanding repeat dispensings at 1 December 2016 and the prescription is endorsed accordingly. From 1 December 2016 until 28 February pharmacists may annotate a prescription as endorsed where the patient has outstanding repeat dispensings at 1 December Inj 3.75 mg prefilled dual chamber syringe Higher subsidy of $ per 1 inj with Endorsement (221.60) Lucrin Depot 1-month Inj 7.5 mg syringe with diluent Higher subsidy of $ per 1 inj with Endorsement (166.20) Eligard 1 Month Inj mg prefilled dual chamber syringe Higher subsidy of $ per 1 inj with Endorsement (591.68) Lucrin Depot 3-month Inj 22.5 mg syringe with diluent Higher subsidy of $ per 1 inj with Endorsement (443.76) Eligard 3 Month Inj 30 mg prefilled dual chamber syringe Higher subsidy of $ per 1 inj with Endorsement (1,109.40) Lucrin Depot 6-month Inj 45 mg syringe with diluent Higher subsidy of $ per 1 inj with Endorsement (832.05) Eligard 6 Month 136 DOSULEPIN [DOTHIEPIN] HYDROCHLORIDE Safety medicine; prescriber may determine dispensing frequency Tab 75 mg Dopress Cap 25 mg Dopress Effective 1 February 25 METFORMIN HYDROCHLORIDE (Sole Supply suspended) Tab immediate-release 850 mg Metformin Mylan 59 METOPROLOL TARTRATE Tab 50 mg Apo-Metoprolol a) Brand switch fee payable (Pharmacode ) b) For metoprolol tartrate oral liquid formulation refer Tab 100 mg Brand switch fee payable (Pharmacode ) Apo-Metoprolol 63 ATORVASTATIN a) See prescribing guideline b) Brand switch fee payable (Pharmacode ) Tab 10 mg Lorstat Tab 20 mg Lorstat Tab 40 mg Lorstat Tab 80 mg Lorstat Three months supply may be dispensed at one time if endorsed certified exemption by the prescriber or pharmacist Three months or six months, as applicable, dispensed all-at-once 27

28 Check your Schedule for full details Subsidy Brand or Schedule page ref (Mnfr s price) Generic Mnfr $ Per fully subsidised Changes to Restrictions effective 1 February (continued) 81 LEVONORGESTREL Subdermal implant (2 x 75 mg rods) Up to 3 pack available on a PSO Jadelle 137 PAROXETINE HYDROCHLORIDE Tab 20 mg Apo-Paroxetine 4.32 Loxamine 145 AMISULPRIDE Safety medicine; prescriber may determine dispensing frequency Tab 100 mg Brand switch fee payable (Pharmacode ) Sulprix Tab 200 mg Brand switch fee payable (Pharmacode ) Sulprix Tab 400 mg Brand switch fee payable (Pharmacode ) Sulprix 260 HUMAN PAPILLOMAVIRUS (6, 11, 16 AND 18) VACCINE [HPV] [Xpharm] Maximum of three doses Funded for patient meeting either any of the following criteria: 1) Maximum of 3 doses for people aged 9 to 26 years inclusive Females aged under 20 years old; or 2) Patients aged under 26 years old with confirmed HIV infection; or 3) For use in transplant (including stem cell) patients; or 2)4) Maximum of four An additional doses for people patients aged 9 to under 26 years inclusive, of age post chemotherapy. Inj 120 mcg in 0.5 ml syringe Gardasil 1 Gardasil Effective 1 January 54 SODIUM CHLORIDE Not funded for use as a nasal drop. Only funded for nebuliser use when in conjunction with an antibiotic intended for nebuliser use. Inj 0.9%, 5 ml ampoule Up to 5 inj available on a PSO InterPharma Multichem Pfizer Inj 0.9%, 10 ml ampoule Up to 5 inj available on a PSO Pfizer Multichem Inj 0.9%, 20 ml ampoule Pharmacia Multichem InterPharma Pharmacia 55 WATER 1) On a prescription or Practitioner s Supply Order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or 2) On a bulk supply order; or 3) When used in the extemporaneous compounding of eye drops. Inj Purified for inj, 5 ml ampoule Up to 5 inj available on a PSO InterPharma Multichem continued... Patients pay a manufacturer s surcharge when the Manufacturer s Price is greater than the Subsidy 28 S29 Unapproved medicine supplied under Section 29 safety cap reimbursed Sole Subsidised Supply